CSL Behring

HAEGARDA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / HAEGARDA – J0599

Manufacturer:

CSL Behring

Name:

HAEGARDA

HCPCS Code Descriptor:

Injection, c-1 esterase inhibitor (human), (haegarda), 10 units

Category:

J Code

HCPCS:

J0599

NDC(s):

63833-0829-02, 63833-0828-02

Primary Type:

Immunology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

HAEGARDA is an Immunology drug manufactured by CSL Behring and administered via the Subcutaneous route of administration. The J Code: J0599 is aligned to the drug HAEGARDA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/19

HCPCS Effective Date:

1/1/22

HCPCS Short Description:

Inj., haegarda 10 units

Billing and Coding Guide:

https://labeling.cslbehring.com/PRODUCT-DOCUMENT/US/HAEGARDA/EN/HAEGARDA-Code-Reimbursement-Guide.pdf

Patient Assistance:

https://www.cslbehring.com/patients/support-and-assistance